4
Changes in Ownership
Jasper Therapeutics, Inc. Filed Acc 0001213900-23-048683
See Remarks sold 9,000 shares at $1.66 ($14,915)
- See Remarks acquired 9,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mahal Jeetinder Singh See Remarks | 2023-06-13 | Option exercise 10b5-1 | +9,000 | $0.71 | $6,390 | 296,223 | D: show line 1 in the form |
| Mahal Jeetinder Singh See Remarks | 2023-06-13 | Sale 10b5-1 | −9,000 | $1.66 | $14,915 | 287,223 | D: show line 2 in the form |
| Open-market sales · 9,000 sh · avg $1.66 · $14,915 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mahal Jeetinder Singh See Remarks | 2023-06-13 | Option exercise · Stock Option (right to buy) 10b5-1 | +9,000 | 173,713 | D: show line 3 in the form |
Loading xslF345X04/ownership.xml…